Teva attracts attention from pharma, private equity for $500M sale of Medis: Bloomberg | Fierce Pharma
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva's New CEO to Cut 25% of Jobs to Rescue Ailing Drugmaker | Fortune
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Intas To Buy Teva's UK, Ireland Assets For 603 Million Pounds
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
The Adderall supply squeeze in the US is growing
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
